Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure
- 1 December 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (6) , 2205-2214
- https://doi.org/10.1046/j.1523-1755.2001.00054.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Ischemic acute renal failureCurrent Opinion in Nephrology and Hypertension, 1998
- Novel Synthetic Inhibitors of Selectin-Mediated Cell Adhesion: Synthesis of 1,6-Bis[3-(3-carboxymethylphenyl)-4-(2-α-d-mannopyranosyloxy)phenyl]hexane (TBC1269)Journal of Medicinal Chemistry, 1998
- Treatment of acute renal failureKidney International, 1998
- An emerging paradigm shift on the role of leukocyte adhesion molecules.Journal of Clinical Investigation, 1997
- The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.Journal of Clinical Investigation, 1997
- Generation and Characterization of a Novel Adhesion Function Blocking Monoclonal Antibody Recognizing Both Rat and Mouse E-SelectinHybridoma, 1997
- Characterization of a Novel Adhesion Function Blocking Monoclonal Antibody to Rat/Mouse P-Selectin Generated in the P-Selectin-Deficient MouseHybridoma, 1997
- Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats.Journal of Clinical Investigation, 1997
- Antibodies to ICAM-1 Protect Kidneys in Severe Ischemic Reperfusion InjuryBiochemical and Biophysical Research Communications, 1995
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994